clopidogrel and Complications of Diabetes Mellitus

clopidogrel has been researched along with Complications of Diabetes Mellitus in 61 studies

Research

Studies (61)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	29 (47.54)	29.6817
2010's	30 (49.18)	24.3611
2020's	2 (3.28)	2.80

Authors

Authors	Studies
Angiolillo, DJ; Bass, TA; Been, L; Briceno, M; Franchi, F; Maaliki, N; Pineda, AM; Rivas, A; Rollini, F; Soffer, D; Suryadevara, S; Wali, M; Zenni, MM	1
Cai, ZX; Dou, KF; Song, WH; Wang, HY; Yang, YJ; Yin, D	1
Assanelli, EM; Camisasca, P; Chizzola, G; Corrada, E; De Servi, S; Demarchi, A; Farina, A; Ferlini, M; Grieco, N; Lettieri, C; Mafrici, A; Musumeci, G; Oltrona Visconti, L; Pedrinazzi, C; Rossini, R; Sponzilli, C	1
Ahn, J; Ahn, JH; Carriere, KC; Cho, SW; Choi, JH; Choi, SH; Gwon, HC; Hahn, JY; Kim, J; Lee, JM; Lee, SH; Lee, SY; Park, K; Park, TK; Song, YB; Yang, JH	1
Baber, U; Badimon, JJ; Bander, J; Gukathasan, N; Hadi, A; Karajgikar, R; Kini, AS; Kovacic, JC; Mehran, R; Moreno, P; Muntner, P; Roy, S; Sartori, S; Sayeneni, S; Scott, SA; Sharma, SK; Theodoropolous, K; Uribarri, J; Yadav, K; Yu, J	1
Ahn, JM; Cho, YR; Han, S; Jang, JY; Kang, SJ; Kim, JJ; Kim, WJ; Kim, YH; Kwon, CH; Lee, CW; Lee, JY; Lee, SW; Lee, WS; Park, DW; Park, GM; Park, SJ; Park, SW; Park, YK	1
Li, G; Li, ZQ; Yang, JD; Yang, QY	1
Sabouret, P; Taiel-Sartral, M	1
Al-Atassi, T; Kulik, A; Le May, M; Ruel, M; Une, D; Voisine, P	1
Bischof, F; Ernemann, U; Silber, T; Ziemann, U	1
Gasior, M; Hawranek, M; Kaczmarski, J; Kuliczkowski, W; Laszowska, A; Polonski, L; Pres, D; Serebruany, VL; Szewczyk, M; Tajstra, M; Zeglen, S	1
Barbato, E; Chenu, P; Legrand, D; Legrand, V; Magne, J; Vrolix, M; Wijns, W	1
Bell, DS	1
He, Y; Jing, J; Li, H; Pan, Y; Wang, Y	1
Barbato, E; Colaiori, I; Di Sciascio, G; Lauria Pantano, A; Mangiacapra, F; Panaioli, E; Pozzilli, P; Ricottini, E	1
Bøttcher, M; Hansen, HH; Jensen, LO; Johnsen, SP; Kaltoft, A; Krusell, LR; Lassen, JF; Maeng, M; Pedersen, L; Rasmussen, K; Sørensen, HT; Thayssen, P; Thuesen, L	1
Ang, L; Bromberg-Marin, G; Clopton, P; Idrees, Z; Keramati, S; Khalid, A; Mahmud, E; Palakodeti, V; Tran, P; Tsimikas, S; Zafar, N	1
Brandt, JT; Braun, OO; Erlinge, D; Jakubowski, JA; James, S; Siegbahn, A; Sugidachi, A; Varenhorst, C; Wallentin, L; Winters, KJ	1
Cairns, JA; Eikelboom, J	1
Siasos, G; Stefanadis, C; Tousoulis, D	1
Motovska, Z; Widimsky, P	1
Armero, S; Barragan, P; Bonello, C; Bonello, L; Bonello-Palot, N; Camoin-Jau, L; De Labriolle, A; Dignat-George, F; Lévy, N; Maillard, L; Mancini, J; Paganelli, F	1
Danenberg, HD; Lotan, C; Marincheva, G; Nassar, H; Varshitzki, B	1
Chae, JK; Cho, YH; Choi, SW; Chun, KJ; Hong, MK; Jeong, JO; Jon, S; Kim, HS; Kim, JH; Kim, WJ; Kim, YH; Ko, JK; Lee, CW; Lee, JH; Lee, JY; Lee, NH; Lee, SW; Park, DW; Park, JH; Park, SJ; Park, SW; Rhee, KS; Seong, IW; Yun, SC	1
Abraham, NG; Ferraris, A; Kruger, AL; McClung, JA; Tsenovoy, P; Vanella, L; Weiss, MB	1
Bareiss, P; Kessler, L; Morel, O; Ohlmann, P	1
Barbato, E; D'Ambrosio, A; Di Sciascio, G; Gatto, L; Mangiacapra, F; Muller, O; Patti, G; Peace, A; Ricottini, E; Vizzi, V	1
Barbato, E; Mangiacapra, F; Peace, AJ; Wijns, W	1
Chung, HS; Han, JY; Kim, HJ; Kim, SR; Lee, SY; Park, KJ	1
Gąsior, M; Greif, M; Kaczmarski, J; Kuliczkowski, W; Poloński, L; Pres, D	1
Carballo, D; Carballo, S; Keller, PF; Roffi, M	1
Demcheva, M; Fischer, TH; Gennaoui, A; Matthews, JC; Orgill, DP; Pietramaggiori, G; Scherer, SS; Valeri, CR	1
Banerjee, S; Hall, HM; McGuire, DK	1
Gammack, JK; Messinger-Rapport, BJ; Morley, JE; Thomas, DR	1
Alfons, MA; Bedeer, I; Darwish, YW; Hassan, AR; Ismail, EA; Nasr, HA; Saad, AA	1
Angiolillo, DJ; Cequier, AR; Ferreiro, JL	1
Linden, MD; Tonkin, A; Tran, H; Woods, R	1
Crimizade, U; El Ghannudi, S; Gachet, C; Hess, S; Jesel, L; Morel, O; Ohlmann, P; Radulescu, B; Reydel, A; Wiesel, ML	1
Alexander, JH; Alexander, KP; Broderick, S; Granger, CB; Hess, CN; Lopes, RD; Mahaffey, KW; Newby, LK; Peterson, ED; Piccini, JP; Shaw, LK	1
Abrams, J; Berra, K; Blankenship, JC; Dallas, AP; Douglas, PS; Fihn, SD; Foody, JM; Gardin, JM; Gerber, TC; Hinderliter, AL; King, SB; Kligfield, PD; Krumholz, HM; Kwong, RY; Lim, MJ; Linderbaum, JA; Mack, MJ; Munger, MA; Prager, RL; Sabik, JF; Shaw, LJ; Sikkema, JD; Smith, CR; Smith, SC; Spertus, JA; Williams, SV	1
Bhatt, DL; Hacke, W; Hirsch, AT; Marso, SP; Ringleb, PA; Topol, EJ	1
Berger, PP; Bollwein, H; Dibra, A; Dirschinger, J; Dotzer, F; Kastrati, A; Mehilli, J; Pache, J; Schömig, A; Schühlen, H; von Beckerath, N	1
Schnell, O; Standl, E	1
Cox, N; Douglas, J; Fitzpatrick, M; Holmes, DR; Kuntz, RE; Lambert, C; Leon, MB; Mooney, M; Moses, JW; Popma, JJ; Yakubov, S	1
Hankey, GJ	1
Alfonso, F; Angiolillo, DJ; Bañuelos, C; Bass, TA; Bernardo, E; Costa, MA; Escaned, J; Fernandez-Ortiz, A; Hernández, R; Jimenez-Quevedo, P; Macaya, C; Moreno, R; Ramírez, C; Sabaté, M	1
Fehér, G; Horváth, B; Késmárky, G; Koltai, K; Tóth, K	1
Kastrati, A; Schömig, A; Sibbing, D; von Beckerath, N; von Beckerath, O	1
Frossard, M; Fuchs, I; Jilma, B; Laggner, AN; Riedmüller, E; Spiel, A	1
Münzel, TF; Post, F	1
Lepor, NE	1
Grinius, V; Navickas, R; Unikas, R	1
Bego, G; Carita, P; Gabriel, S; Hakimi, Z; Hankey, GJ; Spiesser, J	1
Bruskina, O; Iijima, R; Kastrati, A; Mehilli, J; Ndrepepa, G; Schömig, A; Schulz, S	1
Ahn, TH; Ahn, Y; Bae, JH; Chae, IH; Hur, SH; Jeong, JW; Jeong, MH; Kang, WC; Kim, JH; Kim, KH; Kim, KY; Nam, CW; Oh, SK; Park, CG	1
Beyar, R; Nikolsky, E	1
Alessi, MC; Bali, L; Bonnet, JL; Camoin, L; Cuisset, T; Frere, C; Juhan-Vague, I; Lambert, M; Morange, PE; Quilici, J	1
Davis, CJ; Lowry, DR; McKenzie, ME; Nair, GV; Serebruany, VL	1
Brouwer, MA; Verheugt, FW	1
Fonarow, GC; Horwich, TB	1

Reviews

13 review(s) available for clopidogrel and Complications of Diabetes Mellitus

Article	Year
New antiplatelet agents in the treatment of acute coronary syndromes. Archives of cardiovascular diseases, 2014, Volume: 107, Issue:3 Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Clinical Trials as Topic; Clopidogrel; Combined Modality Therapy; Coronary Artery Bypass; Coronary Thrombosis; Diabetes Complications; Hemorrhage; Humans; Multicenter Studies as Topic; Piperazines; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Prasugrel Hydrochloride; Precision Medicine; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Renal Insufficiency; Thiophenes; Ticagrelor; Ticlopidine; Treatment Outcome	2014
Improving outcomes in patients undergoing percutaneous coronary intervention: role of prasugrel. Vascular health and risk management, 2009, Volume: 5, Issue:1 Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Thrombosis; Diabetes Complications; Drug Resistance; Drug Therapy, Combination; Humans; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Risk Assessment; Risk Factors; Stents; Thiophenes; Ticlopidine; Treatment Outcome	2009
Diabetes and the platelet: toward new therapeutic paradigms for diabetic atherothrombosis. Atherosclerosis, 2010, Volume: 212, Issue:2 Topics: Acute Coronary Syndrome; Apoptosis; Aspirin; Blood Platelets; Clopidogrel; Diabetes Complications; Diabetes Mellitus; Glycoproteins; Humans; Models, Biological; Piperazines; Platelet Activation; Prasugrel Hydrochloride; Receptors, Purinergic P2Y12; Thiophenes; Thromboplastin; Thrombosis; Ticlopidine	2010
Variability of clopidogrel response in patients with type 2 diabetes mellitus. Diabetes & vascular disease research, 2011, Volume: 8, Issue:4 Topics: Clopidogrel; Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Monitoring; Drug Resistance; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2Y Receptor Antagonists; Ticlopidine; Treatment Outcome	2011
Oral antiplatelet therapy in patients with diabetes mellitus and acute coronary syndromes. Trends in cardiovascular medicine, 2010, Volume: 20, Issue:7 Topics: Acute Coronary Syndrome; Administration, Oral; Aspirin; Cilostazol; Clopidogrel; Diabetes Complications; Humans; Platelet Aggregation Inhibitors; Tetrazoles; Ticlopidine; Treatment Outcome	2010
High platelet reactivity and antiplatelet therapy resistance. Seminars in thrombosis and hemostasis, 2012, Volume: 38, Issue:2 Topics: Aged; Biological Availability; Blood Platelets; Clopidogrel; Cyclooxygenase 1; Diabetes Complications; Drug Resistance; Humans; Patient Compliance; Platelet Activation; Platelet Aggregation; Ticlopidine	2012
[Cardiovascular risk in diabetes--diagnostic and therapeutic aspects]. MMW Fortschritte der Medizin, 2004, Sep-02, Volume: 146, Issue:35-36 Topics: Abciximab; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal; Aspirin; Blood Glucose; Cardiovascular Diseases; Clinical Trials as Topic; Clopidogrel; Diabetes Complications; Diabetes Mellitus; Follow-Up Studies; Glucose Tolerance Test; Humans; Hypolipidemic Agents; Immunoglobulin Fab Fragments; Insulin; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Primary Prevention; Risk; Risk Factors; Stents; Ticlopidine; Time Factors	2004
Secondary prevention of recurrent stroke. Stroke, 2005, Volume: 36, Issue:2 Topics: Aspirin; Clinical Trials as Topic; Clopidogrel; Diabetes Complications; Endarterectomy; Endarterectomy, Carotid; Fibrinolytic Agents; Homocysteine; Humans; Platelet Aggregation Inhibitors; Risk; Risk Factors; Secondary Prevention; Stents; Stroke; Ticlopidine; Vitamin B Complex	2005
[Pathogenesis and therapy of the acute coronary syndrome: differentiated advantage of glycoprotein IIb/IIIa receptor antagonists for high-risk patients]. Deutsche medizinische Wochenschrift (1946), 2006, Nov-24, Volume: 131, Issue:47 Suppl 7 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Coronary Thrombosis; Diabetes Complications; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Renal Insufficiency; Risk Factors; Syndrome; Ticlopidine; Tirofiban; Troponin; Tyrosine	2006
Impact of chronic kidney disease and diabetes on percutaneous coronary intervention outcomes. Reviews in cardiovascular medicine, 2006, Volume: 7 Suppl 4 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Cardiovascular Diseases; Clinical Trials as Topic; Clopidogrel; Coronary Artery Disease; Diabetes Complications; Drug-Eluting Stents; Glucose; Humans; Immunoglobulin Fab Fragments; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Renal Insufficiency, Chronic; Risk Assessment; Risk Factors; Ticlopidine; Treatment Outcome	2006
[Stents in interventional cardiology]. Medicina (Kaunas, Lithuania), 2007, Volume: 43, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Anti-Bacterial Agents; Anti-Inflammatory Agents; Aspirin; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Diabetes Complications; Drug Delivery Systems; Drug Therapy, Combination; Fibrinolytic Agents; Follow-Up Studies; Humans; Immunosuppressive Agents; Middle Aged; Platelet Aggregation Inhibitors; Prednisolone; Randomized Controlled Trials as Topic; Risk Factors; Sirolimus; Stents; Ticlopidine; Time Factors; Treatment Outcome	2007
Aspirin in patients with coronary artery disease: is it simply irresistible? Journal of thrombosis and thrombolysis, 2001, Volume: 11, Issue:2 Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Benzamidines; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Cyclooxygenase Inhibitors; Diabetes Complications; Dipyridamole; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Endothelium, Vascular; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Oximes; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Randomized Controlled Trials as Topic; Stroke; Thrombosis; Thromboxane-A Synthase; Ticlopidine; Vasodilator Agents	2001
Prevention of heart failure. Current cardiology reports, 2002, Volume: 4, Issue:3 Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Antihypertensive Agents; Clinical Trials as Topic; Clopidogrel; Coronary Artery Disease; Diabetes Complications; Disease Progression; Health Behavior; Heart Failure; Humans; Hyperlipidemias; Hypertension; Platelet Aggregation Inhibitors; Prevalence; Renal Insufficiency; Risk Factors; Smoking; Ticlopidine; Ventricular Dysfunction, Left	2002

Trials

13 trial(s) available for clopidogrel and Complications of Diabetes Mellitus

Article	Year
Pharmacodynamic and Pharmacokinetic Effects of a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Previous Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention: Th Circulation, 2020, 10-13, Volume: 142, Issue:15 Topics: Adult; Aged; Cardiovascular Diseases; Clopidogrel; Diabetes Complications; Elective Surgical Procedures; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies; Ticagrelor	2020
Comparison of dual versus triple antiplatelet therapy after drug-eluting stent according to stent length (from the pooled analysis of DECLARE trials). The American journal of cardiology, 2013, Dec-01, Volume: 112, Issue:11 Topics: Aged; Aspirin; Cilostazol; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Diabetes Complications; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prosthesis Implantation; Tetrazoles; Ticlopidine; Treatment Outcome	2013
The STIB score: a simple clinical test to predict clopidogrel resistance. Acta cardiologica, 2015, Volume: 70, Issue:5 Topics: Aged; Angina, Stable; Angioplasty, Balloon, Coronary; Belgium; Biomarkers; Blood Platelets; Body Mass Index; Chi-Square Distribution; Clopidogrel; Comorbidity; Decision Support Techniques; Diabetes Complications; Drug Resistance; Female; Hemoglobins; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Obesity; Odds Ratio; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Point-of-Care Testing; Predictive Value of Tests; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome	2015
Abnormal glucose regulation increases stroke risk in minor ischemic stroke or TIA. Neurology, 2016, Oct-11, Volume: 87, Issue:15 Topics: Aged; Aspirin; Blood Glucose; Brain Ischemia; Clopidogrel; Diabetes Complications; Double-Blind Method; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Risk; Stroke; Ticlopidine; Treatment Outcome	2016
Clopidogrel Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients Treated With Percutaneous Coronary Intervention: Results of the CLOTILDIA Study (Clopidogrel High Dose Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients). Circulation, 2016, Sep-13, Volume: 134, Issue:11 Topics: Adenosine; Clopidogrel; Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Ticagrelor; Ticlopidine	2016
Patients with poor responsiveness to thienopyridine treatment or with diabetes have lower levels of circulating active metabolite, but their platelets respond normally to active metabolite added ex vivo. Journal of the American College of Cardiology, 2008, Dec-09, Volume: 52, Issue:24 Topics: Adult; Aged; Clopidogrel; Comorbidity; Coronary Artery Disease; Diabetes Complications; Double-Blind Method; Drug Resistance; Female; Humans; Male; Middle Aged; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prevalence; Pyridines; Thiophenes; Ticlopidine; Treatment Failure; Treatment Outcome	2008
Comparison of Triple antiplatelet therapy and dual antiplatelet therapy in patients at high risk of restenosis after drug-eluting stent implantation (from the DECLARE-DIABETES and -LONG Trials). The American journal of cardiology, 2010, Jan-15, Volume: 105, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Coronary Restenosis; Diabetes Complications; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Tetrazoles; Ticlopidine; Treatment Outcome	2010
Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. The American journal of cardiology, 2002, Sep-15, Volume: 90, Issue:6 Topics: Aged; Aspirin; Clopidogrel; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Endpoint Determination; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Patient Readmission; Platelet Aggregation Inhibitors; Predictive Value of Tests; Risk Factors; Ticlopidine; Treatment Outcome	2002
Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel. Circulation, 2004, Dec-14, Volume: 110, Issue:24 Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Diabetes Complications; Elective Surgical Procedures; Endpoint Determination; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk; Stents; Ticlopidine	2004
Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries. Circulation, 2004, Dec-21, Volume: 110, Issue:25 Topics: Aged; Aspirin; Clopidogrel; Coronary Aneurysm; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Diabetes Complications; Double-Blind Method; Drug Implants; Drug Therapy, Combination; Female; Follow-Up Studies; Heparin; Humans; Incidence; Male; Middle Aged; Randomized Controlled Trials as Topic; Sirolimus; Stents; Ticlopidine; Treatment Outcome	2004
Diabetes mellitus and platelet function after administration of aspirin and a single 600 mg dose of clopidogrel. Journal of thrombosis and haemostasis : JTH, 2006, Volume: 4, Issue:12 Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Aspirin; Blood Platelets; Clopidogrel; Collagen; Coronary Artery Disease; Diabetes Complications; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Receptors, Thrombin; Thrombosis; Ticlopidine	2006
Relationship between platelet count and 30-day clinical outcomes after percutaneous coronary interventions. Pooled analysis of four ISAR trials. Thrombosis and haemostasis, 2007, Volume: 98, Issue:4 Topics: Abciximab; Acute Coronary Syndrome; Aged; Angiography; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Blood Platelets; Clopidogrel; Diabetes Complications; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Platelet Count; Ticlopidine; Time Factors; Treatment Outcome	2007
Randomized comparison of cilostazol vs clopidogrel after drug-eluting stenting in diabetic patients--clilostazol for diabetic patients in drug-eluting stent (CIDES) trial. Circulation journal : official journal of the Japanese Circulation Society, 2008, Volume: 72, Issue:1 Topics: Aged; Aspirin; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Diabetes Complications; Drug Therapy, Combination; Drug-Eluting Stents; Humans; Male; Middle Aged; Tetrazoles; Ticlopidine; Treatment Outcome	2008

Other Studies

35 other study(ies) available for clopidogrel and Complications of Diabetes Mellitus

Article	Year
Benefits and Risks of Prolonged Duration Dual Antiplatelet Therapy (Clopidogrel and Aspirin) After Percutaneous Coronary Intervention in High-Risk Patients With Diabetes Mellitus. The American journal of cardiology, 2021, 03-01, Volume: 142 Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus; Dual Anti-Platelet Therapy; Duration of Therapy; Female; Hemorrhage; Humans; Male; Middle Aged; Mortality; Multivariate Analysis; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Care; Proportional Hazards Models; Registries; Risk Assessment; Stroke	2021
The paradox of clopidogrel use in patients with acute coronary syndromes and diabetes: insight from the Diabetes and Acute Coronary Syndrome Registry. Coronary artery disease, 2018, Volume: 29, Issue:4 Topics: Acute Coronary Syndrome; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Clopidogrel; Diabetes Complications; Diabetes Mellitus; Humans; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Prasugrel Hydrochloride; Prospective Studies; Registries; Ticagrelor	2018
Extended Clopidogrel Therapy Beyond 12 Months and Long-Term Outcomes in Patients With Diabetes Mellitus Receiving Coronary Arterial Second-Generation Drug-Eluting Stents. The American journal of cardiology, 2018, 09-01, Volume: 122, Issue:5 Topics: Aged; Clopidogrel; Coronary Artery Disease; Diabetes Complications; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Treatment Outcome	2018
Combined and independent impact of diabetes mellitus and chronic kidney disease on residual platelet reactivity. Thrombosis and haemostasis, 2013, Volume: 110, Issue:1 Topics: Aged; Clopidogrel; Diabetes Complications; Diabetes Mellitus; Female; Humans; Kidney Diseases; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Activation; Platelet Function Tests; Preoperative Care; Prospective Studies; Receptors, Purinergic P2Y12; Risk; Thrombosis; Ticlopidine; Treatment Outcome	2013
Acquired pure red cell aplasia due to treatment with clopidogrel: first case report. Journal of thrombosis and thrombolysis, 2014, Volume: 38, Issue:2 Topics: Clopidogrel; Coronary Disease; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Humans; Hyperlipidemias; Hypertension; Middle Aged; Platelet Aggregation Inhibitors; Red-Cell Aplasia, Pure; Ticlopidine	2014
Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial. Circulation, 2014, Sep-09, Volume: 130, Issue:11 Suppl 1 Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Restenosis; Coronary Stenosis; Diabetes Complications; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Risk Factors; Ticlopidine	2014
Analysis of periinterventional complications of intracranial angioplasty and stenting: a single center experience. European journal of radiology, 2014, Volume: 83, Issue:12 Topics: Aged; Angioplasty; Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Diabetes Complications; Female; Humans; Hyperlipidemias; Hypertension; Intracranial Arteriosclerosis; Male; Middle Aged; Platelet Aggregation Inhibitors; Reperfusion Injury; Retrospective Studies; Stents; Stroke; Ticlopidine	2014
Aspirin 'resistance': impact on no-reflow, platelet and inflammatory biomarkers in diabetics after ST-segment elevation myocardial infarction. Cardiology, 2015, Volume: 131, Issue:1 Topics: Aged; Aspirin; Biomarkers; Clopidogrel; Diabetes Complications; Drug Resistance; Female; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine	2015
Aspirin in the prevention of cardiovascular events in patients with diabetes. Postgraduate medicine, 2016, Volume: 128, Issue:2 Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Diabetes Complications; Diabetes Mellitus; Drug Administration Schedule; Half-Life; Humans; Platelet Aggregation Inhibitors; Ticlopidine	2016
Comparison of stent thrombosis, myocardial infarction, and mortality following drug-eluting versus bare-metal stent coronary intervention in patients with diabetes mellitus. The American journal of cardiology, 2008, Jul-15, Volume: 102, Issue:2 Topics: Aged; Aspirin; Clopidogrel; Denmark; Diabetes Complications; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Stents; Thrombosis; Ticlopidine; Treatment Outcome	2008
Elevated plasma fibrinogen and diabetes mellitus are associated with lower inhibition of platelet reactivity with clopidogrel. Journal of the American College of Cardiology, 2008, Sep-23, Volume: 52, Issue:13 Topics: Aged; Body Mass Index; Cardiovascular Diseases; Clopidogrel; Diabetes Complications; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Ticlopidine	2008
The pursuit of clinically relevant measures of platelet function after antiplatelet drug therapy. Journal of the American College of Cardiology, 2008, Dec-09, Volume: 52, Issue:24 Topics: Blood Platelets; Clopidogrel; Coronary Artery Disease; Diabetes Complications; Humans; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyridines; Risk Factors; Thiophenes; Ticlopidine; Treatment Failure	2008
Multiple mechanisms affect the clopidogrel response. Journal of the American College of Cardiology, 2009, Mar-10, Volume: 53, Issue:10 Topics: Biomarkers; Cardiovascular Diseases; Clopidogrel; Cytochrome P-450 Enzyme System; Diabetes Complications; Fibrinogen; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Ticlopidine	2009
Relation of body mass index to high on-treatment platelet reactivity and of failed clopidogrel dose adjustment according to platelet reactivity monitoring in patients undergoing percutaneous coronary intervention. The American journal of cardiology, 2009, Dec-01, Volume: 104, Issue:11 Topics: Aged; Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Body Mass Index; Clopidogrel; Coronary Artery Disease; Cytochrome P-450 CYP2C19; Diabetes Complications; Dose-Response Relationship, Drug; Female; France; Genetic Markers; Genotype; Humans; Male; Middle Aged; Monitoring, Physiologic; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Predictive Value of Tests; Prospective Studies; Risk Factors; Ticlopidine	2009
Stent thrombosis: a poor man's disease? The Israel Medical Association journal : IMAJ, 2009, Volume: 11, Issue:9 Topics: Acute Disease; Aged; Angioplasty, Balloon, Coronary; Chi-Square Distribution; Clopidogrel; Cohort Studies; Coronary Disease; Data Interpretation, Statistical; Diabetes Complications; Drug-Eluting Stents; Female; Follow-Up Studies; Housing; Humans; Male; Metals; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Polytetrafluoroethylene; Residential Facilities; Risk Factors; Smoking; Socioeconomic Factors; Stents; Thrombosis; Ticlopidine; Time Factors	2009
Usefulness of clopidogrel to protect against diabetes-induced vascular damage. The American journal of cardiology, 2010, Apr-01, Volume: 105, Issue:7 Topics: Adult; Aged; Cell Count; Clopidogrel; Diabetes Complications; Diabetes Mellitus, Type 2; Endothelial Cells; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine; Vascular Diseases	2010
Comparison of platelet reactivity and periprocedural outcomes in patients with versus without diabetes mellitus and treated with clopidogrel and percutaneous coronary intervention. The American journal of cardiology, 2010, Sep-01, Volume: 106, Issue:5 Topics: Aged; Angioplasty, Balloon, Coronary; Case-Control Studies; Clopidogrel; Cohort Studies; Coronary Stenosis; Diabetes Complications; Female; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Ticlopidine; Treatment Outcome	2010
Lack of correlation between platelet reactivity and glycaemic control in type 2 diabetes mellitus patients treated with aspirin and clopidogrel. Journal of thrombosis and thrombolysis, 2011, Volume: 32, Issue:1 Topics: Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Blood Glucose; Blood Platelets; Clopidogrel; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Glycemic Index; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticlopidine; Time Factors	2011
Clinical, pharmacokinetic, and pharmacogenetic determinants of clopidogrel resistance in Korean patients with acute coronary syndrome. The Korean journal of laboratory medicine, 2011, Volume: 31, Issue:2 Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Aryl Hydrocarbon Hydroxylases; Asian People; Clopidogrel; Cytochrome P-450 CYP2C19; Diabetes Complications; Drug Resistance; Female; Genotype; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Republic of Korea; Ticlopidine	2011
Effects of platelet and inflammatory system activation on outcomes in diabetic patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Kardiologia polska, 2011, Volume: 69, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Restenosis; Diabetes Complications; Electrocardiography; Female; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome	2011
[Specificities of diabetes in acute coronary syndromes]. Revue medicale suisse, 2011, Jun-01, Volume: 7, Issue:297 Topics: Acute Coronary Syndrome; Algorithms; Angioplasty; Anti-Inflammatory Agents, Non-Steroidal; Clopidogrel; Diabetes Complications; Diabetes Mellitus; Drug Therapy, Combination; Enoxaparin; Evidence-Based Medicine; Fibrinolytic Agents; Heparin; Humans; Hypoglycemic Agents; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prasugrel Hydrochloride; Randomized Controlled Trials as Topic; Risk Factors; Secondary Prevention; Stents; Thiophenes; Ticlopidine; Treatment Outcome	2011
Poly-N-acetyl glucosamine fibers induce angiogenesis in ADP inhibitor-treated diabetic mice. The Journal of trauma, 2011, Volume: 71, Issue:2 Suppl 1 Topics: Acetylglucosamine; Animals; Clopidogrel; Diabetes Complications; Male; Mice; Mice, Inbred C57BL; Nanofibers; Neovascularization, Physiologic; Purinergic P2Y Receptor Antagonists; Ticlopidine; Wound Healing; Wounds and Injuries	2011
Clinical update on nursing home medicine: 2011. Journal of the American Medical Directors Association, 2011, Volume: 12, Issue:9 Topics: Anti-Ulcer Agents; Anticoagulants; Atrial Fibrillation; Clopidogrel; Clostridioides difficile; Delirium; Diabetes Complications; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Female; Fractures, Bone; Geriatric Nursing; Humans; Male; Nursing Homes; Omeprazole; Osteoporosis; Peptic Ulcer; Platelet Aggregation Inhibitors; Pneumonia, Bacterial; Polypharmacy; Proton Pump Inhibitors; Risk Factors; Ticlopidine; Warfarin; Weight Loss	2011
Platelet function profile post-clopidogrel therapy in patients with type 2 diabetes undergoing coronary stent implantation. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2012, Volume: 18, Issue:3 Topics: Aged; Clopidogrel; Coronary Vessels; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Stents; Ticlopidine	2012
The extent of P2Y12 inhibition by clopidogrel in diabetes mellitus patients with acute coronary syndrome is not related to glycaemic control: roles of white blood cell count and body weight. Thrombosis and haemostasis, 2012, Volume: 108, Issue:2 Topics: Acute Coronary Syndrome; Aged; Body Weight; Clopidogrel; Diabetes Complications; Diabetes Mellitus; Female; Flow Cytometry; Glycated Hemoglobin; Humans; Inflammation; Leukocyte Count; Leukocytes; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Percutaneous Coronary Intervention; Phosphorylation; Proportional Hazards Models; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Ticlopidine	2012
Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients. American heart journal, 2012, Volume: 164, Issue:4 Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Diabetes Complications; Female; Fibrinolytic Agents; Heart Failure; Humans; Hypertension; Male; Risk Assessment; Stroke; Ticlopidine; Treatment Outcome; Warfarin	2012
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the Journal of the American College of Cardiology, 2012, Dec-18, Volume: 60, Issue:24 Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Alcohol Drinking; Angina Pectoris; Body Weight; Cholesterol, LDL; Clopidogrel; Comorbidity; Cost of Illness; Depression; Diabetes Complications; Disease Management; Electrocardiography; Exercise; Exercise Test; Glycated Hemoglobin; Health Behavior; Humans; Hypertension; Life Style; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Physical Examination; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Quality of Life; Risk Assessment; Risk Factors; Risk Reduction Behavior; Smoking Cessation; Ticlopidine	2012
[Even when walking yet does not cause any pain, peripheral arterial occlusive disease costs life years]. MMW Fortschritte der Medizin, 2003, Apr-10, Volume: 145, Issue:15 Topics: Arterial Occlusive Diseases; Clinical Trials as Topic; Clopidogrel; Diabetes Complications; Humans; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine; Walking	2003
Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery disease. Diabetes, 2006, Volume: 55, Issue:3 Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus; Female; Humans; Inflammation; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Substance Withdrawal Syndrome; Thrombosis; Ticlopidine	2006
Viscosity, hemostasis and inflammation in atherosclerotic heart diseases. Clinical hemorheology and microcirculation, 2006, Volume: 35, Issue:1-2 Topics: Aged; Aspirin; Blood Viscosity; Brain Ischemia; Clopidogrel; Coronary Artery Disease; Diabetes Complications; Female; Glucose; Glycated Hemoglobin; Hemostasis; Humans; Inflammation; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine; von Willebrand Factor	2006
Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS. Journal of thrombosis and haemostasis : JTH, 2006, Volume: 4, Issue:12 Topics: Acute Disease; Adrenergic beta-Antagonists; Aspirin; Clopidogrel; Coronary Disease; Diabetes Complications; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Odds Ratio; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Recurrence; Research Design; Risk Assessment; Stress, Mechanical; Syndrome; Ticlopidine; Time Factors; von Willebrand Factor	2006
Rate, degree, and predictors of recovery from disability following ischemic stroke. Neurology, 2007, May-08, Volume: 68, Issue:19 Topics: Aged; Brain Ischemia; Causality; Clopidogrel; Cohort Studies; Diabetes Complications; Disability Evaluation; Female; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Predictive Value of Tests; Prognosis; Prospective Studies; Recovery of Function; Regression Analysis; Stroke; Ticlopidine; Time Factors; Treatment Outcome	2007
Drug-eluting versus bare-metal stents: when and for whom? The Journal of invasive cardiology, 2008, Volume: 20, Issue:3 Topics: Angioplasty, Balloon, Coronary; Canada; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Diabetes Complications; Drug-Eluting Stents; Health Care Costs; Humans; Patient Selection; Platelet Aggregation Inhibitors; Stents; Ticlopidine	2008
Relationship between aspirin and clopidogrel responses in acute coronary syndrome and clinical predictors of non response. Thrombosis research, 2009, Volume: 123, Issue:4 Topics: Acute Coronary Syndrome; Age Factors; Aged; Arachidonic Acid; Aspirin; Body Mass Index; Cell Adhesion Molecules; Clopidogrel; Diabetes Complications; Drug Resistance; Humans; Male; Microfilament Proteins; Middle Aged; Phosphoproteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine	2009
Oral anticoagulation for acute coronary syndromes. Circulation, 2002, Mar-19, Volume: 105, Issue:11 Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Clopidogrel; Controlled Clinical Trials as Topic; Diabetes Complications; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Humans; International Normalized Ratio; Male; Middle Aged; Myocardial Infarction; Patient Care Planning; Risk Factors; Stroke; Thrombosis; Ticlopidine; Warfarin	2002